Examining a stock’s 52-week price history, encompassing its low and high prices, can reveal much about its existing condition and potential future trajectory. Prime Medicine Inc’s current trading price is -28.81% away from its 52-week high, while its distance from the 52-week low is 332.88%. The stock’s price range over this period has fluctuated between $1.11 and $6.75. The company, operating within the financial sector, had a trading volume of approximately 4.67 million for the day, which was noticeably higher than the average daily share volume of 3.07 million over the last 3 months.
The stock price for Prime Medicine Inc (PRME) currently stands at $4.8. The stock experienced a substantial increase in the last session, hitting $18.0 after starting at $4.8. The stock’s lowest price was $1.5 before closing at $4.35.
In terms of market performance, Prime Medicine Inc had a fairly even. The highest value for the stock in the past year was $6.75 on 07/16/24, and the lowest value was recorded at $1.11 on 05/22/25.
Exploring Financial Performance and Market Capitalization: A Comprehensive Analysis
Prime Medicine Inc (PRME) has experienced a quarterly rise of 310.68% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 630.87M and boasts a workforce of 214 employees.
Prime Medicine Inc: What Analysts Are Saying
As of right now, 6 analysts are rating Prime Medicine Inc as a BUY, 2 of the polled analysts branded the stock as an OVERWEIGHT, 4 analysts are recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 analyst is rating the stock as SELL.
Analyzing Trading Volume and Moving Average Trends
Based on Barchart.com data, the company’s moving average over the 100-day period was 1.95, with a change in price of +1.81. Similarly, Prime Medicine Inc recorded 2,495,640 in trading volume during the last 100 days, posting a change of +60.70%.
Understanding Ticker ‘s Debt-to-Equity Ratio: An Analysis
The debt-to-equity (D/E) ratio serves as an important indicator of a company’s financial stability and market position. By dividing a company’s total liabilities by its shareholders’ equity, the D/E ratio reveals the degree to which a company relies on debt to finance assets compared to its shareholders’ equity. At the time of writing, the total D/E ratio for PRME stands at 1.13. Similarly, the long-term debt-to-equity ratio is also 1.07.
PRME Stock Stochastic Average
Today’s raw stochastic average for Prime Medicine Inc over the last 50 days is 99.19%.This indicates a increase from the raw stochastic average of the past 20 days, which was 99.13%. Moreover, the company’s Stochastic %K and %D values for the last 20 days were 93.68% and 93.12%, respectively.
PRME Stock Price Performance Analysis
A mixed performance in the stock price over the year has left investors with either an optimistic or pessimistic outlook, depending on their point of view. This year’s metric has recorded a Price decrease of -13.42%. However, over the past six months, we’ve seen a weaker performance of 52.54%. The price of PRME fallen by 214.05% over the last 30 days. And in the last five days, it has surged by 26.45%.
